Exploring the influence of the gut microbiota and probiotics on health: a symposium report.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 4077244)

Published in Br J Nutr on July 01, 2014

Authors

Linda V Thomas1, Theo Ockhuizen2, Kaori Suzuki3

Author Affiliations

1: Yakult UK Limited,Odyssey Business Park, West End Road, South Ruislip,MiddlesexHA4 6QQ,UK.
2: Nutricom Consultancy,Dorpsdijk 10,4156 AKRumpt,The Netherlands.
3: Yakult Europe B.V.,Schutsluisweg 1,1332 ENAlmere,The Netherlands.

Articles citing this

Intestinal microbiota as modulators of the immune system and neuroimmune system: impact on the host health and homeostasis. J Immunol Res (2015) 1.06

First arrived takes all: inhibitory priority effects dominate competition between co-infecting Borrelia burgdorferi strains. BMC Microbiol (2015) 0.90

Probiotics as Complementary Treatment for Metabolic Disorders. Diabetes Metab J (2015) 0.82

Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a review. Clin Exp Gastroenterol (2015) 0.79

Effects of exposure to bisphenol A and ethinyl estradiol on the gut microbiota of parents and their offspring in a rodent model. Gut Microbes (2016) 0.78

Infectious Gastroenteritis as a Risk Factor for Tropical Sprue and Malabsorption: A Case-Control Study. Dig Dis Sci (2015) 0.78

Early-life enteric infections: relation between chronic systemic inflammation and poor cognition in children. Nutr Rev (2016) 0.76

What goes around comes around: novel pharmacological targets in the gut-brain axis. Therap Adv Gastroenterol (2016) 0.75

Perinatal Bisphenol A Exposure Induces Chronic Inflammation in Rabbit Offspring via Modulation of Gut Bacteria and Their Metabolites. mSystems (2017) 0.75

Early pregnancy probiotic supplementation with Lactobacillus rhamnosus HN001 may reduce the prevalence of gestational diabetes mellitus: a randomised controlled trial. Br J Nutr (2017) 0.75

Assessing the Risk of Probiotic Dietary Supplements in the Context of Antibiotic Resistance. Front Microbiol (2017) 0.75

Articles cited by this

(truncated to the top 100)

A core gut microbiome in obese and lean twins. Nature (2008) 52.30

Diversity of the human intestinal microbial flora. Science (2005) 49.64

An obesity-associated gut microbiome with increased capacity for energy harvest. Nature (2006) 44.35

A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 43.63

Microbial ecology: human gut microbes associated with obesity. Nature (2006) 36.98

Metagenomic analysis of the human distal gut microbiome. Science (2006) 29.76

The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A (2004) 26.56

Enterotypes of the human gut microbiome. Nature (2011) 24.36

Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med (2013) 20.65

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A (2007) 20.60

Human gut microbiome viewed across age and geography. Nature (2012) 19.31

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A (2008) 14.18

Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes (2007) 14.12

Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr (1995) 13.30

Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res (2007) 13.08

Recognition of microorganisms and activation of the immune response. Nature (2007) 12.99

A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature (2012) 11.68

Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A (2010) 11.21

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes (2008) 10.74

Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol (2005) 9.70

The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med (2002) 9.26

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab (2005) 9.14

Functional interactions between the gut microbiota and host metabolism. Nature (2012) 7.91

Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics (2006) 7.40

Gut microbiota composition correlates with diet and health in the elderly. Nature (2012) 6.94

Genomic islands in pathogenic and environmental microorganisms. Nat Rev Microbiol (2004) 6.94

Richness of human gut microbiome correlates with metabolic markers. Nature (2013) 6.93

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut (2009) 6.50

Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology (2004) 6.47

Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature (2013) 6.07

Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A (2013) 5.88

A model of host-microbial interactions in an open mammalian ecosystem. Science (1996) 5.85

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol (2012) 5.66

Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia (2007) 5.61

Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J (2010) 5.43

Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A (2010) 5.02

Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine. PLoS One (2009) 4.93

Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab (2013) 4.88

Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol (2011) 4.57

Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev (2009) 4.55

Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J Exp Med (2006) 4.53

Genomic variation landscape of the human gut microbiome. Nature (2012) 4.38

Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science (2012) 4.20

Comparison of two next-generation sequencing technologies for resolving highly complex microbiota composition using tandem variable 16S rRNA gene regions. Nucleic Acids Res (2010) 4.17

Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog (2012) 3.81

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut (2004) 3.80

Pathogenicity islands in bacterial pathogenesis. Clin Microbiol Rev (2004) 3.77

A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc Natl Acad Sci U S A (1999) 3.63

Dietary intervention impact on gut microbial gene richness. Nature (2013) 3.56

Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol (2006) 3.55

Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology (1995) 3.44

Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol (2006) 3.39

The role of gut hormones in glucose homeostasis. J Clin Invest (2007) 3.36

Interactions and competition within the microbial community of the human colon: links between diet and health. Environ Microbiol (2007) 3.29

Bile acids as regulatory molecules. J Lipid Res (2009) 3.23

Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response. Nature (2009) 3.18

The 'hygiene hypothesis' for autoimmune and allergic diseases: an update. Clin Exp Immunol (2010) 3.17

Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. Gut (2011) 3.11

Differential roles of segmented filamentous bacteria and clostridia in development of the intestinal immune system. Infect Immun (1999) 3.03

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut (2004) 3.01

Intestinal bacteria and ageing. J Appl Microbiol (2007) 2.91

Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin Microbiol Rev (2008) 2.86

Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun (2012) 2.84

Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS One (2010) 2.82

Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol (2004) 2.66

Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology (2011) 2.52

Microbial degradation of complex carbohydrates in the gut. Gut Microbes (2012) 2.51

Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease. Hum Mol Genet (2010) 2.51

Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes (2011) 2.46

Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol (2011) 2.44

The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology (2011) 2.41

Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int J Syst Evol Microbiol (2002) 2.35

The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol (2009) 2.35

Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut (2013) 2.32

Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut (2004) 2.29

High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am J Clin Nutr (2011) 2.26

pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl Environ Microbiol (2005) 2.19

Alterations in intestinal permeability. Gut (2006) 2.17

Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther (2012) 2.11

Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. J Bacteriol (2004) 2.09

Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin Microbiol Rev (2009) 2.09

Microbiology: the inside story. Nature (2008) 2.07

Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model. Gut (2012) 2.02

Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J (2012) 2.02

Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr (2009) 2.00

Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice. Gut (2012) 1.99

Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol (2009) 1.91

Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol (2007) 1.90

Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ Microbiol (2009) 1.89

The role of pH in determining the species composition of the human colonic microbiota. Environ Microbiol (2009) 1.87

Intestinal colonization resistance. Immunology (2013) 1.85

Dendritic cells in intestinal homeostasis and disease. J Clin Invest (2009) 1.83

The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol (2010) 1.79

Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol (2013) 1.79

The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol (2010) 1.79

Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. Arch Dis Child (2005) 1.74

The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing. Ann Surg (2010) 1.69

Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol (2008) 1.68

Indigenous opportunistic bacteria inhabit mammalian gut-associated lymphoid tissues and share a mucosal antibody-mediated symbiosis. Proc Natl Acad Sci U S A (2010) 1.67